Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Palliative Medicine in Practice
MENU
Shortcuts Submit an article Author Guidelines Reviewers 2023 Editorial Team Focus and Scope

open access

Vol 11, No 3 (2017)
Review paper
Published online: 2017-12-21
View PDF (Polish) Download PDF file
Get Citation

Anxiety and depression in cancer patients — what do we lose?

Szymon Gołota1, Katarzyna Białczyk2, Zofia Wyszkowska3, Alicja Popiołek1, Małgorzata Krajnik4, Alina Borkowska1
Medycyna Paliatywna w Praktyce 2017;11(3):111-117.
Affiliations
  1. Department of Clinical Neuropsychology, Faculty of Health Sciences, Nicolaus Copernicus University in Toruń, Collgium Medicum in Bydgoszcz
  2. Katedra Zdrowia Publicznego, Zakład Ekonomiki Zdrowia, Wydział Nauk o Zdrowiu, Uniwersytet im Mikołaja Kopernika w Toruniu, Collegium Medicum w Bydgoszczy
  3. Uniwersytet Technologiczno-Przyrodniczy w Bydgoszczy, Wydział Zarządzania, Katedra Organizacji i Zarządzania
  4. Katedra i Zakład Opieki Paliatywnej, Wydział Nauk o Zdrowiu, Uniwersytet im Mikołaja Kopernika w Toruniu, Collegium Medicum w Bydgoszczy

open access

Vol 11, No 3 (2017)
Review paper
Published online: 2017-12-21

Abstract

Depression and anxiety is a serious medical problem in about 50% of cancer patients. Depression may worse treatment, course of the illness, psychosocial functioning and quality of patients life and significantly increases mortality as well. The costs of depression is difficulty to account, however in global cost of cancer treatment more and more often medical and social cost of depression is taken into account, however individual patients and caregivers costs are not included in these analyses.

Abstract

Depression and anxiety is a serious medical problem in about 50% of cancer patients. Depression may worse treatment, course of the illness, psychosocial functioning and quality of patients life and significantly increases mortality as well. The costs of depression is difficulty to account, however in global cost of cancer treatment more and more often medical and social cost of depression is taken into account, however individual patients and caregivers costs are not included in these analyses.

Full Text:

View PDF (Polish) Download PDF file
Get Citation

Keywords

depression, anxiety, cancer, economic and social lost

About this article
Title

Anxiety and depression in cancer patients — what do we lose?

Journal

Palliative Medicine in Practice

Issue

Vol 11, No 3 (2017)

Article type

Review paper

Pages

111-117

Published online

2017-12-21

Page views

551

Article views/downloads

4389

Bibliographic record

Medycyna Paliatywna w Praktyce 2017;11(3):111-117.

Keywords

depression
anxiety
cancer
economic and social lost

Authors

Szymon Gołota
Katarzyna Białczyk
Zofia Wyszkowska
Alicja Popiołek
Małgorzata Krajnik
Alina Borkowska

References (44)
  1. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62(6): 593–602.
    CrossRefPubMed
  2. Kennedy N, Paykel ES. Residual symptoms at remission from depression: impact on long-term outcome. J Affect Disord. 2004; 80(2-3): 135–144.
    CrossRefPubMed
  3. Kessler R, Üstün T. The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Method Psych Res. 2006; 13(2): 93–121.
    CrossRef
  4. Stein DJ, Hollander E. Współchorobowość depresji i zaburzeń lękowych. Via Medica, Gdańsk 2004.
  5. Jaeschke R, Siwek M, Grabski B. Współwystępowanie zaburzeń depresyjnych i lękowych. Psychiatria. 2010; 7: 189–197.
  6. Murawiec S. Depresja u osób z chorobą nowotworową. Rozpoznawanie i leczenie – aspekty praktyczne. OncoReview. 2012; 2: 201–208.
  7. Nesse R. Emotional disorders in evolutionary perspective. Br J Med Psychol. 2011; 71(4): 397–415.
    CrossRef
  8. De Walden-Gałuszko K. Zaburzenia psychiczne w przebiegu choroby nowotworowej. Curr Gynecol Oncol. 2013; 11: 302–321.
  9. International Classification of Diseases. Wyd. 10. WHO, Geneva, 1995.
  10. Wells KB, Golding JM, Burnam MA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry. 1988; 145(8): 976–981.
    CrossRefPubMed
  11. Patten SB. Long-term medical conditions and major depression in the Canadian population. Can J Psychiatry. 1999; 44(2): 151–157.
    CrossRefPubMed
  12. Dudek D, Siwek M. Współistnienie depresji i chorób somatycznych. Psychiatria. 2007; 4: 17–24.
  13. Karakoyun-Celik O, Gorken I, Sahin S, et al. Depression and anxiety levels in woman under follow-up for breast cancer: relationship to coping with cancer and quality of life. Med Oncol. 2010; 27(1): 108–113.
    CrossRefPubMed
  14. Onitilo AA, Nietert PJ, Egede LE. Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry. 2006; 28(5): 396–402.
    CrossRefPubMed
  15. Chan CM, Wan Ahmad WA, Yusof MMD, et al. Effects of depression and anxiety on mortality in a mixed cancer group: a longitudinal approach using standardised diagnostic interviews. Psychooncology. 2015; 24(6): 718–725.
    CrossRefPubMed
  16. Pasquini M, Biondi M. Depression in cancer patients: a critical review. Clin Pract Epidemiol Ment Health. 2007; 3: 1–9.
  17. Lueboonthavatchai P. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. J Med Assoc Thai. 2007; 90(10): 2164–2174.
    PubMed
  18. Krebber AMH, Buffart LM, Kleijn G, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology. 2014; 23(2): 121–130.
    CrossRefPubMed
  19. Hofman M, Ryan JL, Figueroa-Moseley CD, et al. Cancer-related fatigue: the scale of the problem. Oncologist. 2007; 12 Suppl 1: 4–10.
    CrossRefPubMed
  20. Polsky D, Doshi JA, Marcus S, et al. Long-term risk for depressive symptoms after a medical diagnosis. Arch Intern Med. 2005; 165(11): 1260–1266.
    CrossRefPubMed
  21. Vodermaier A, Linden W, MacKenzie R, et al. Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer. Br J Cancer. 2011; 105(12): 1814–1817.
    CrossRefPubMed
  22. Cardoso G, Graca J, Klut C, et al. Depression and anxiety symptoms following cancer diagnosis: a cross-sectional study. Psychol Health Med. 2016; 21(5): 562–570.
    CrossRefPubMed
  23. Paterson C, Robertson A, Nabi G. Exploring prostate cancer survivors' self-management behaviours and examining the mechanism effect that links coping and social support to health-related quality of life, anxiety and depression: a prospective longitudinal study. Eur J Oncol Nurs. 2015; 19(2): 120–128.
    CrossRefPubMed
  24. Maraste R, Brandt L, Olsson H, et al. Anxiety and depression in breast cancer patients at start of adjuvant radiotherapy. Relations to age and type of surgery. Acta Oncol. 1992; 31(6): 641–643.
    CrossRefPubMed
  25. Astrup GL, Rustøen T, Miaskowski C, et al. A Longitudinal Study of Depressive Symptoms in Patients With Head and Neck Cancer Undergoing Radiotherapy. Cancer Nurs. 2015; 38(6): 436–446.
    CrossRefPubMed
  26. Neilson K, Pollard A, Boonzaier A, et al. A longitudinal study of distress (depression and anxiety) up to 18 months after radiotherapy for head and neck cancer. Psychooncology. 2013; 22(8): 1843–1848.
    CrossRefPubMed
  27. Parker G, Brotchie H. Pancreatic Cancer and Depression: A Narrative Review. J Nerv Ment Dis. 2017; 205(6): 487–490.
    CrossRefPubMed
  28. Linden W, MacKenzie R, Rnic K, et al. Emotional adjustment over 1 year post-diagnosis in patients with cancer: understanding and predicting adjustment trajectories. Support Care Cancer. 2015; 23(5): 1391–1399.
    CrossRefPubMed
  29. Schroevers M, Ranchor AV, Sanderman R. Adjustment to cancer in the 8 years following diagnosis: a longitudinal study comparing cancer survivors with healthy individuals. Soc Sci Med. 2006; 63(3): 598–610.
    CrossRefPubMed
  30. Wilson KG, Chochinov HM, Skirko MG, et al. Depression and anxiety disorders in palliative cancer care. J Pain Symptom Manage. 2007; 33(2): 118–129.
    CrossRefPubMed
  31. Liang X, Margolis KL, Hendryx M, et al. Effect of depression before breast cancer diagnosis on mortality among postmenopausal women. Cancer. 2017; 123(16): 3107–3115.
    CrossRefPubMed
  32. Liang JW, Cheung YK, Willey JZ, et al. Quality of life independently predicts long-term mortality but not vascular events: the Northern Manhattan Study. Qual Life Res. 2017; 26(8): 2219–2228.
    CrossRefPubMed
  33. Batty GD, Russ TC, Stamatakis E, et al. Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies. BMJ. 2017; 356: j108.
    CrossRefPubMed
  34. Majkowicz M. Wybrane problemy psychoonkologii z uwzględnieniem zagadnień psychiatrycznych. Psychiatria w Praktyce Klinicznej. 2008; 1: 57–66.
  35. Siracuse BL, Gorgy G, Ruskin J, et al. What is the Incidence of Suicide in Patients with Bone and Soft Tissue Cancer? : Suicide and Sarcoma. Clin Orthop Relat Res. 2017; 475(5): 1439–1445.
    CrossRefPubMed
  36. Lavielle-Sotomayor P, Rozen-Fuller E, Bustamante-Rojano J, et al. [Optimism, family cohesion and treatment as predictors of quality of life in blood cancer diseases]. Rev Med Inst Mex Seguro Soc. 2017; 55(4): 456–463.
    PubMed
  37. Kim ES, Hagan KA, Grodstein F, et al. Optimism and Cause-Specific Mortality: A Prospective Cohort Study. Am J Epidemiol. 2017; 185(1): 21–29.
    CrossRefPubMed
  38. Boursi B, Lurie I, Haynes K, et al. Chronic therapy with selective serotonin reuptake inhibitors and survival in newly diagnosed cancer patients. Eur J Cancer Care (Engl). 2017 [Epub ahead of print].
    CrossRefPubMed
  39. Mihailovic N, Kocic S, Jakovljevic M. Review of Diagnosis-Related Group-Based Financing of Hospital Care. Health Serv Res Manag Epidemiol. 2016; 3: 2333392816647892.
    CrossRefPubMed
  40. Dagovic A, Matter Walstra K, Gutzwiller SF, et al. Resource use and costs of newly diagnosed cancer initial medical care. Eur J Oncol. 2014; 19: 166–184.
  41. Kovacević A, Dragojević-Simić V, Rancić N, et al. End-of-life costs of medical care for advanced stage cancer patients. Vojnosanit Pregl. 2015; 72(4): 334–341.
    CrossRefPubMed
  42. Nabhan C, Feinberg BA. Value-Based Calculators in Cancer: Current State and Challenges. J Oncol Pract. 2017; 13(8): 499–506.
    CrossRefPubMed
  43. Titler MG, Visovatti MA, Shuman C, et al. Effectiveness of implementing a dyadic psychoeducational intervention for cancer patients and family caregivers. Support Care Cancer. 2017 [Epub ahead of print].
    CrossRefPubMed
  44. Dockham B, Schafenacker A, Yoon H, et al. Implementation of a Psychoeducational Program for Cancer Survivors and Family Caregivers at a Cancer Support Community Affiliate: A Pilot Effectiveness Study. Cancer Nurs. 2016; 39(3): 169–180.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl